DK0627918T3 - Ny anvendelse af omega-3-fedtsyrer - Google Patents
Ny anvendelse af omega-3-fedtsyrerInfo
- Publication number
- DK0627918T3 DK0627918T3 DK93905710T DK93905710T DK0627918T3 DK 0627918 T3 DK0627918 T3 DK 0627918T3 DK 93905710 T DK93905710 T DK 93905710T DK 93905710 T DK93905710 T DK 93905710T DK 0627918 T3 DK0627918 T3 DK 0627918T3
- Authority
- DK
- Denmark
- Prior art keywords
- omega
- pct
- preparations
- fatty acids
- dic
- Prior art date
Links
- 235000020660 omega-3 fatty acid Nutrition 0.000 title abstract 4
- 229940012843 omega-3 fatty acid Drugs 0.000 title abstract 4
- 239000006014 omega-3 oil Substances 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 abstract 4
- 208000009190 disseminated intravascular coagulation Diseases 0.000 abstract 2
- 239000000443 aerosol Substances 0.000 abstract 1
- 230000004872 arterial blood pressure Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 210000001147 pulmonary artery Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9200541A SE9200541D0 (sv) | 1992-02-24 | 1992-02-24 | New usee of omega-3-fatty acids |
| PCT/SE1993/000146 WO1993016691A1 (en) | 1992-02-24 | 1993-02-23 | New use of omega-3-fatty acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0627918T3 true DK0627918T3 (da) | 2002-01-14 |
Family
ID=20385410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93905710T DK0627918T3 (da) | 1992-02-24 | 1993-02-23 | Ny anvendelse af omega-3-fedtsyrer |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US5747533A (da) |
| EP (1) | EP0627918B1 (da) |
| JP (1) | JP3559280B2 (da) |
| AT (1) | ATE207744T1 (da) |
| AU (1) | AU671438B2 (da) |
| CA (1) | CA2117535A1 (da) |
| DE (1) | DE69331051T2 (da) |
| DK (1) | DK0627918T3 (da) |
| ES (1) | ES2162620T3 (da) |
| NO (1) | NO309704B1 (da) |
| SE (1) | SE9200541D0 (da) |
| SG (1) | SG46238A1 (da) |
| WO (1) | WO1993016691A1 (da) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0987176A (ja) * | 1995-09-26 | 1997-03-31 | Shiseido Co Ltd | 糸球体腎炎抑制剤 |
| US6313167B1 (en) * | 1997-06-16 | 2001-11-06 | Nippon Suisan Kaisha Ltd. | Composition having capability of removing risk factor during exercise |
| BR9917806B1 (pt) * | 1998-01-21 | 2013-06-18 | composiÇço de feromona para tratamento de estresse ou ansiedade em mamÍferos, e soluÇço. | |
| US6054481A (en) | 1998-01-21 | 2000-04-25 | Fideline | Pig appeasing pheromones for enhancing weight gain in a mammal |
| EP0948963B1 (en) * | 1998-01-21 | 2003-05-07 | Fideline | Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| AU784123B2 (en) * | 1999-10-13 | 2006-02-09 | Marco A. Chacon | Therapeutic intervention to mimic the effect of caloric restriction |
| FR2804023B1 (fr) * | 2000-01-26 | 2002-09-20 | Johnson & Johnson Consumer Fr | Complement nutritionnel a base d'huile de pepins de cassis |
| US6864242B2 (en) * | 2001-03-05 | 2005-03-08 | Stephen P. Ernest | Enteral formulation |
| US8729124B2 (en) * | 2002-03-05 | 2014-05-20 | Pronova Biopharma Norge As | Use of EPA and DHA in secondary prevention |
| US7323206B1 (en) | 2003-03-04 | 2008-01-29 | B. Braun Medical Inc. | Reagents and methods for all-in-one total parenteral nutrition for neonates and infants |
| US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
| US9592324B2 (en) | 2006-11-06 | 2017-03-14 | Atrium Medical Corporation | Tissue separating device with reinforced support for anchoring mechanisms |
| WO2007011385A2 (en) | 2004-09-28 | 2007-01-25 | Atrium Medical Corporation | Heat cured gel and method of making |
| US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| WO2006037049A2 (en) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Application of a coating on a medical device |
| US20060135610A1 (en) * | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Cardiovascular compositions |
| BRPI0613137A2 (pt) * | 2005-06-24 | 2010-12-21 | Drugrecure Aps | administração em vias aéreas de proteìna c ativada em condições inflamatórias afetando o trato respiratório |
| US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
| US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
| CA2641852A1 (en) * | 2006-02-10 | 2007-08-16 | Sportscom Danmark Aps | Coated tablets, their methods of preparation, and related uses |
| US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
| US20080207756A1 (en) * | 2007-02-27 | 2008-08-28 | Atrium Medical Corporation | Bio-absorbable oil suspension |
| CA2692394A1 (en) * | 2007-07-06 | 2009-01-15 | Seth J. Baum | Fatty acid compositions and methods of use |
| CA2702577A1 (en) | 2007-10-15 | 2009-04-23 | Jbs United, Inc. | Method for increasing performance of offspring |
| WO2009058799A1 (en) * | 2007-11-01 | 2009-05-07 | Wake Forest University School Of Medicine | Compositions and methods for prevention and treatment of mammalian diseases |
| US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| US20100323028A1 (en) * | 2007-11-30 | 2010-12-23 | Jbs United, Inc. | Method and composition for treating pulmonary hemorrhage |
| US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
| US20110045050A1 (en) * | 2009-08-24 | 2011-02-24 | Atrium Medical Corporation | Nanoemulsion formulations for direct delivery |
| WO2011103514A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | Dha triglyceride emulsions |
| WO2011103512A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | Dha free fatty acid emulsions |
| EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
| US20210176999A1 (en) | 2011-04-17 | 2021-06-17 | Omega Foods, LLC | Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids |
| US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
| US9549937B2 (en) | 2013-12-05 | 2017-01-24 | Burvia, LLC. | Composition containing phospholipid-DHA and folate |
| US9233114B2 (en) | 2013-12-05 | 2016-01-12 | Buriva, LLC | Dietary supplement containing phospholipid-DHA derived from eggs |
| US9610302B2 (en) | 2013-12-05 | 2017-04-04 | Buriva, LLC. | Composition containing phospholipid-DHA and B vitamins |
| US9216199B2 (en) | 2013-12-05 | 2015-12-22 | Buriva, LLC | Nutritional supplement containing phospholipid-DHA derived from eggs |
| US10183044B2 (en) * | 2015-05-15 | 2019-01-22 | P Tech, Llc | Systems and methods for thrombosis prevention |
| US9655847B1 (en) * | 2016-07-18 | 2017-05-23 | National Guard Health Affairs | Therapeutic liposome and method of treating a subject having cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4752618A (en) * | 1984-07-12 | 1988-06-21 | New England Deaconess Hospital | Method of minimizing efects of infection through diet |
| US4678808A (en) * | 1985-10-15 | 1987-07-07 | Baxter Travenol Laboratories, Inc. | Rapid acting intravenous emulsions of omega-3 fatty acid esters |
| DE3785667T2 (de) * | 1986-09-17 | 1994-07-21 | Clintec Nutrition Co | Zusatznahrung bzw. therapie für personen mit risiko oder in behandlung für arteriosklerotische vaskuläre, kardiovaskuläre und/oder thrombotische erkrankungen. |
| DE3719097C1 (de) * | 1987-06-06 | 1988-06-09 | Fratzer Uwe | Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E |
| GB8729751D0 (en) * | 1987-12-21 | 1988-02-03 | Norsk Hydro As | Feed additive & feed containing such additive |
| GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| US5223285A (en) * | 1992-03-31 | 1993-06-29 | Abbott Laboratories | Nutritional product for pulmonary patients |
-
1992
- 1992-02-24 SE SE9200541A patent/SE9200541D0/xx unknown
-
1993
- 1993-02-23 SG SG1996001422A patent/SG46238A1/en unknown
- 1993-02-23 DE DE69331051T patent/DE69331051T2/de not_active Expired - Lifetime
- 1993-02-23 JP JP51475493A patent/JP3559280B2/ja not_active Expired - Lifetime
- 1993-02-23 CA CA002117535A patent/CA2117535A1/en not_active Abandoned
- 1993-02-23 WO PCT/SE1993/000146 patent/WO1993016691A1/en not_active Ceased
- 1993-02-23 AU AU36529/93A patent/AU671438B2/en not_active Ceased
- 1993-02-23 US US08/290,905 patent/US5747533A/en not_active Expired - Lifetime
- 1993-02-23 ES ES93905710T patent/ES2162620T3/es not_active Expired - Lifetime
- 1993-02-23 EP EP93905710A patent/EP0627918B1/en not_active Expired - Lifetime
- 1993-02-23 AT AT93905710T patent/ATE207744T1/de active
- 1993-02-23 DK DK93905710T patent/DK0627918T3/da active
-
1994
- 1994-08-23 NO NO943102A patent/NO309704B1/no not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/483,977 patent/US5731346A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993016691A1 (en) | 1993-09-02 |
| JPH07507766A (ja) | 1995-08-31 |
| ATE207744T1 (de) | 2001-11-15 |
| US5731346A (en) | 1998-03-24 |
| CA2117535A1 (en) | 1993-09-02 |
| EP0627918B1 (en) | 2001-10-31 |
| JP3559280B2 (ja) | 2004-08-25 |
| ES2162620T3 (es) | 2002-01-01 |
| NO309704B1 (no) | 2001-03-19 |
| SG46238A1 (en) | 1998-02-20 |
| DE69331051T2 (de) | 2002-06-13 |
| AU671438B2 (en) | 1996-08-29 |
| AU3652993A (en) | 1993-09-13 |
| DE69331051D1 (de) | 2001-12-06 |
| SE9200541D0 (sv) | 1992-02-24 |
| NO943102L (no) | 1994-10-21 |
| EP0627918A1 (en) | 1994-12-14 |
| NO943102D0 (no) | 1994-08-23 |
| US5747533A (en) | 1998-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO943102D0 (no) | Ny anvendelse av omega-3-fettsyrer | |
| ATE216227T1 (de) | Phospholipide | |
| US5562913A (en) | Formulation for use in smokers | |
| PT1229800E (pt) | Emulsao contendo agua e oleo | |
| KR910004199A (ko) | 수성 이고제형 제약 조성물 | |
| FI970298A0 (fi) | DHA:n käyttö farmaseuttisena koostumuksena | |
| Brown et al. | Dietary protein intake and the glomerular adaptations to partial nephrectomy in dogs | |
| DE59002572D1 (de) | Omega-3-fettsäurenhaltige fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung. | |
| AU600502B2 (en) | Body lubricating and cleansing fluid | |
| SE8801710D0 (sv) | New ophtalmological composition of matter | |
| DE69005459D1 (de) | Anreicherungsverfahren der fette an polyungesättigten fettsäuren und phospholipiden und anwendung dieser angereicherten fette. | |
| NO891220D0 (no) | Middel som inneholder salicylsyre for behandling av lepidose. | |
| FR2773712B1 (fr) | Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a | |
| DE3584131D1 (de) | Methode zur behandlung der antidiurese. | |
| FR2363324A1 (fr) | Solutions aqueuses ou hydroalcooliques stables d'essences parfumees ou de medicaments solubles dans l'huile | |
| DK0746551T3 (da) | Optisk rene 4-aryl-2-hydroxytetronsyrer | |
| ES2074264T3 (es) | Esteres de aminoacidos de la hidroquinona, su procedimiento de preparacion y composiciones farmaceuticas o cosmeticas que los contienen. | |
| ATE213634T1 (de) | Verwendung von prostaglandinen zur herstellung eines arzneimittels zur prävention und behandlung des sekundären katarakts | |
| KR880010762A (ko) | 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers) | |
| ATE215368T1 (de) | Verwendung von forskolin oder diese enthaltende extrakte zur herstellung eines medikaments für die behandlung von alkoholsucht | |
| JPS57209218A (en) | Antithrombotic | |
| JPS5449336A (en) | Skin cream | |
| ATE312611T1 (de) | Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen | |
| Wenan | Effects of dietary polyunsaturated fatty acids and proteins on serum lipid profiles and renal functions of uremic rats | |
| Unsworth | HTLV-III infection in spouses of haemophiliacs |